Nautilus Biotechnology
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $9,600 |
Gross Profit | -1,619 | -1,633 | -1,625 | -6,353 |
EBITDA | -11,955 | -13,400 | -14,988 | -11,241 |
EBIT | -13,574 | -15,033 | -16,613 | -17,594 |
Net Income | -13,574 | -15,033 | -16,613 | -17,594 |
Net Change In Cash | 0 | 0 | 0 | 9,600 |
Free Cash Flow | -11,452 | -13,746 | -14,156 | -14,563 |
Cash | 23,875 | 34,457 | 33,238 | 27,646 |
Basic Shares | 126,218 | 126,175 | 124,919 | 125,796 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -6,353 | -5,705 | -3,416 | -2,842 |
EBITDA | -64,427 | -74,303 | -54,508 | -47,473 |
EBIT | -70,780 | -76,152 | -57,924 | -50,315 |
Net Income | -70,780 | -63,675 | -57,924 | -50,315 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -70,984 | 149,242 | ||
Free Cash Flow | -61,267 | -54,153 | -48,130 | -41,510 |
Cash | 27,646 | 19,397 | 114,523 | 185,619 |
Basic Shares | 125,427 | 124,919 | 124,589 | 84,464 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.11 |
2025-06-30 | -$0.12 |
2025-03-31 | -$0.13 |
